ArticleGenetics and molecular biology2020

Engineered scPDL1-DM1 drug conjugate with improved in vitro analysis to target PD-L1 positive cancer cells and intracellular trafficking studies in cancer therapy.

Muhammad Kalim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.